REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
BT BIOXCEL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BT BIOXCEL THERAPEUTICS
ST13
US500000088885185Class
5, 42
Filing
88885185
Registration
6359361
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/26/2026
Trademark type
Word
Nice classes
5, 42
Filing date
04/23/2020
Registration date
05/25/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2017-03-00
First use in commerce
2017-03-00
Drawing code
4
Owner type
03
Owner location
New Haven, CT, US
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bioxcel Therapeutics, Inc.
Representatives
Brendan J. Hughes COOLEY LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions
Class 42
Pharmaceutical research and development in the fields of neuroscience and immuno-oncology
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/25/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/23/2020
GNRT
NON-FINAL ACTION E-MAILED
07/23/2020
CNRT
NON-FINAL ACTION WRITTEN
07/23/2020
DOCK
ASSIGNED TO EXAMINER
07/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2020
NWAP
NEW APPLICATION ENTERED
04/27/2020
Continuous trademark protection
Get notified about every new filing that threatens BT BIOXCEL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.